I seem to know what is going to happen to OXGN almost to the penny, while everyone else lives in denial. Maybe I am the man who is in control of the whole thing.... maybe you should all listen to my warnings. Now I am off to impregnate your wives just like I did to Mary a few thousand years ago.
I estimate that OXGN would be trading over $3 a share right now, if I never started bashing. It is because of me sharing truth that potential traders and investors have saved their money by avoiding this stock. Just think how bad they would all feel on November 11th, if they did buy in and then lost 60% of their money overnight. I am saving millions for hard working Americans everywhere.....I am BoobieButtFart.
Why else would this stock constantly fall in price. No respect for OXGN because they do not deserve it. they deserve to be a sub penny scrub trading on the pinks... and guess where they will be a year from now.
I said small gap then sell off to a red close and what happened....Exactly that. Loser longs are crying, baggies are having suicidal thoughts, and all of you need to really ask yourselves. If Boobie has been right all along, is he also correct that the Avastin combo data will fail and the study will be abandoned??? Find out in November when this trades below $1. You heard it here first.
Wrong...the only announcement you will get by then is that they have their 4th patient enrolled. Maybe you will get readout data from one patient, but is that statistically significant. For example if someone did a study on 5 people to see if they are jerkoofs, but only one patient was enrolled and his name was rootbound, the study would show a positive that people are jerkoofs, even though the other that are clones of Boobie had not been fully enrolled. Once you get full readout you would see that only 20% are jerkoofs(root) and 80% are not Boobie. So even though you get a readout it is irrelevant, just like every other study OXGN has ever done. In the end they all fail.
I'll be damned. Does this mean that they are trying to get away from the name Zybrestat since is associated with failure....Like in the upcoming results from the avastin combo trial.
Ha, you guys just cant win... I felt bad for you when OXGN went months without making a peep and your stock collapsed, now they are back to presenting at conferences and initiating new trials and no one cares. You got to wonder if for some miracle they had positive full readout results in November, what would happen to the stock would it go up 10 cents. Loser longs
Maybe you should dig a little deeper into OXGN's science. They are not the same. Fos is a different formulation while still a VDA.
They have traded less than 10,000 shares....pathetic.
It is actually the complete opposite. I actually know something about biotech investing. You should know that by now. I am short in OXGN and in a much better position that all the baggie longs. but you know what, lose your money, I don't care.
They are prepping Fosbretabulin to be the leading drug candidate. By proceeding with the phase II trial they are indicating that they know the full results of the Avastin/Zybrestat combo study failed and that they will now focus on the future. When investing in OXGN you should value the company based on their cash and the future of Fosbretabulin, because Zybrestat is as good as dead at this point. Do you really want to invest $2.30 a share in a company that is going to run a phase II study on only 20 patients with the primary endpoint the lowering of a bio marker. Don't fall for the latest penny scam and avoid OXGN at all costs.
Now that they have more that doubled the amount of shares outstanding they are no longer a low float and flippers have not interest in running the stock on news. All you will get out of this is a 10% bump at the most that will sell off before the end of the day as underwater traders look for an opportunity to get out before it falls under $2.
The study has one patient enrolled and full enrollment of 20 patients will take over a year, then it will be at least another 18 months before they have results. So even if they are good that is 2 and a half years from you. Do you have 30 months to watch your investment in this company dwindle as you wait for results, that will most likely fail???? It is up to you.
OMG you are probably the dumbest person on this board. This news actually clues us in that they have failed in their other trial, that is why they are changing focus to this new development. They will ride this trial for the next three years. Financing a few more times along the way and living large while your ownership in the company vanishes. Sucks to be long in OXGN
Bid and Ask already dropping in After hours on minimal action. Looks like that news has really sparked investor interest.